BofA Upgrades United Rentals, Says COVID Vaccine A Potential 'Cure' For Industry

A potential vaccine against COVID-19 is a potential "cure" for non-residential equipment rental companies like United Rentals, Inc. URI, according to BofA Securities.

The United Rentals Analyst: Ross Gilardi upgraded United Rentals' stock from Neutral to Buy with a price target lifted from $209 to $275.

The United Rentals Thesis: Gilardi said United Rentals' direct exposure to construction and industrial customers, utilities and municipalities bode well ahead of a potential COVID-19 vaccine. Specifically, industrial production is showing signs of a rebound while rental time utilization is recovering.

While encouraging, there aren't enough "pockets of strength" to support a rebound and this is where the vaccine fits into the bullish narrative.

Industrial MRO (35% of rental revenue) should benefit the most from pent up maintenance needs while urban infrastructure maintenance projects on hold could pick up after the vaccine.

Meanwhile, management's tone during its third-quarter earnings conference sounded "a little more positive" on capital spending. The company isn't committing to any specific number but expectations for a repeat of $900 million in gross capital spending "seems very low."

Encouragingly, Gilardi said United Rentals' stock starts to outperform when capital spending reaches a bottom. While the outperformance already started, the stock still has upside potential as "we think the bias is upwards on capex in 2021."

URI Price Action: Shares of United Rentals were trading higher by 1.7% Friday morning at $220.80.

Photo credit: Adam Keethler, via Wikimedia Commons

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsBofA SecuritiesEquipment RentalRoss Gilardivaccine
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!